Julie S. Torode, Director of Strategic Partnerships, Patient and Community Engagement, Institute of Cancer Policy at King’s College London, shared a post on LinkedIn:
“Great news for the new year for cancer researchers in low and middle income countries!
Rising Tide Group has launched a new funding opportunity, the ACCESS Award, to support interventional clinical trials, exploring innovative, affordable, and scalable solutions to improve outcomes and equity, particularly in low- and middle-income countries (LMICs).
The award is up to USD 500,000 for a maximum of 5 years. Proposals should respond to the question –
How can low-cost, scalable interventions—such as AI-driven tools, drug repurposing, and dose optimization—redefine cancer treatment and expand access for patients worldwide?
Learn more here.”
More posts featuring Julie S. Torode.